US Edition
News from Pharmaphorum
If you want to know if Pharmaphorum is credible or reliable, look no further. We rank Pharmaphorum as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaDo you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Pharmaphorum News
CDC · United StatesHealth and Human Services (HHS) Secretary Robert F. Kennedy Jr. tapped five new members to the Centers for Disease Control and Prevention’s (CDC) outside vaccine advisory panel, just days ahead of its next meeting.
See the Story
Five new members named to influential CDC vaccine advisory committee days ahead of key meeting
77% Center coverage: 57 sources
Vaccines · United StatesU.S. Health Secretary Robert F. Kennedy Jr. told former CDC Director Susan Monarez two days before she was fired that the childhood vaccination schedule would change in September, Monarez told a Senate panel on Wednesday.See the Story
Fired CDC director says Kennedy plans to change children's vaccine schedule
65% Left coverage: 17 sources
Donald Trump · United StatesPresident Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years appeared first on MedCity News.See the Story
GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years
50% Center coverage: 16 sources
